A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)
PHASE2
The study was a phase 2 multi-cohort, non-randomized, open-label, multi-cen...
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)
PHASE2
The study is a phase 2 non-randomized, open-label, multi-cohort, multi-cent...
A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]
PHASE2
This is a phase 2 multi-cohort, un-controlled, non-randomized, open-label, ...